Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-30602267

ABSTRACT

A total of 108 marine bacteria were isolated from the deep sea sediment of Bay of Bengal, India. Of which, 15 bacteria showed antimicrobial activity against human pathogenic bacteria. These antagonistic marine bacteria were characterized phenotypically and their taxonomic affiliations were made on the basis of 16S rRNA gene homology and molecular phylogeny tree analysis, the antagonistic marine bacteria were identified as the species of Bacillus, Halobacillus, Staphylococcus, Marinobacter. The extracts of potent marine bacteria exhibited differential cytotoxicity towards lung (A549), cervical (HeLa), breast (MCF-7) and colon (HT-29) cancer cells. The acridine-orange and ethidium bromide (AO/EB) staining of the extract of strain MB30-treated cancer cells showed typical characteristics of apoptosis such as nuclear condensation, cell shrinkage and formation of apoptotic bodies. Present investigation, reports potent marine bacteria from the deep sea sediment of Bay of Bengal that exhibit broad-spectrum antimicrobial and cytotoxicity potential. Due to their innate bioactive potential, these bacteria can be used as the source of potent molecules.

2.
Spectrochim Acta A Mol Biomol Spectrosc ; 183: 90-102, 2017 Aug 05.
Article in English | MEDLINE | ID: mdl-28441541

ABSTRACT

Drug molecule interaction with human serum albumin (HSA) affects the distribution and elimination of the drug. The compound, 2,4-diacetylphloroglucinol (DAPG) has been known for its antimicrobial, antiviral, antihelminthic and anticancer properties. However, its interaction with HSA is not yet reported. In this study, the interaction between HSA and DAPG was investigated through steady-state fluorescence, time-resolved fluorescence (TRF), circular dichroism (CD), Fourier transform infrared (FT-IR) spectroscopy, isothermal titration calorimetry (ITC), molecular docking and molecular dynamics simulation (MDS). Fluorescence spectroscopy results showed the strong quenching of intrinsic fluorescence of HSA due to interaction with DAPG, through dynamic quenching mechanism. The compound bound to HSA with reversible and moderate affinity which explained its easy diffusion from circulatory system to target tissue. The thermodynamic parameters from fluorescence spectroscopic data clearly revealed the contribution of hydrophobic forces but, the role of hydrogen bonds was not negligible according to the ITC studies. The interaction was exothermic and spontaneous in nature. Binding with DAPG reduced the helical content of protein suggesting the unfolding of HSA. Site marker fluorescence experiments revealed the change in binding constant of DAPG in the presence of site I (warfarin) but not site II marker (ibuprofen) which confirmed that the DAPG bound to site I. ITC experiments also supported this as site I marker could not bind to HSA-DAPG complex while site II marker was accommodated in the complex. In silico studies further showed the lowest binding affinity and more stability of DAPG in site I than in site II. Thus the data presented in this study confirms the binding of DAPG to the site I of HSA which may help in further understanding of pharmacokinetic properties of DAPG.


Subject(s)
Phloroglucinol/analogs & derivatives , Serum Albumin, Human/chemistry , Serum Albumin, Human/metabolism , Calorimetry , Humans , Molecular Docking Simulation , Phloroglucinol/chemistry , Phloroglucinol/metabolism , Protein Binding , Spectrometry, Fluorescence , Thermodynamics
3.
Int J Biol Macromol ; 96: 200-213, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27956098

ABSTRACT

Akt, a serine/threonine protein kinase, is often hyper activated in breast and prostate cancers, but with poor prognosis. Allosteric inhibitors regulate aberrant kinase activity by stabilizing the protein in inactive conformation. Several natural compounds have been reported as inhibitors for kinases. In this study, to identify potential natural allosteric inhibitor for Akt1, we generated a seven-point pharmacophore model and screened it through natural compound library. Quercetin-7-O-ß-d-glucopyranoside or Q7G was found to be the best among selected molecules based on its hydrogen bond occupancy with key allosteric residues, persistent polar contacts and salt bridges that stabilize Akt1 in inactive conformation and minimum binding free energy during molecular dynamics simulation. Q7G induced dose-dependent inhibition of breast cancer cells (MDA MB-231) and arrested them in G1 and sub-G phase. This was associated with down-regulation of anti-apoptotic protein Bcl-2, up-regulation of cleaved caspase-3 and PARP. Expression of p-Akt (Ser473) was also down-regulated which might be due to Akt1 inhibition in inactive conformation. We further confirmed the Akt1 and Q7G interaction which was observed to have a dissociation constant (Kd) of 0.246µM. With these computational, biological and thermodynamic studies, we suggest Q7G as a lead molecule and propose for its further optimization.


Subject(s)
Biological Products/pharmacology , Molecular Dynamics Simulation , Proto-Oncogene Proteins c-akt/chemistry , Proto-Oncogene Proteins c-akt/metabolism , Allosteric Regulation/drug effects , Apoptosis/drug effects , Biological Products/chemistry , Cell Cycle Checkpoints/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Drug Evaluation, Preclinical , Humans , Phosphorylation/drug effects , Protein Conformation , Quantitative Structure-Activity Relationship , Thermodynamics , User-Computer Interface
4.
Bioinformation ; 9(19): 958-62, 2013.
Article in English | MEDLINE | ID: mdl-24391357

ABSTRACT

A new glucanolytic bacterial strain, SU40 was isolated, and identified as Bacillus subtilis on the basis of 16S rRNA sequence homology and phylogenetic tree analysis. The gene encoding ß-1,3-1,4-glucanase was delineated, cloned into pET 28a+ vector and heterologously overexpressed in Escherichia coli BL21(DE3). The purified recombinant enzyme was about 24 kDa. The enzyme exhibited maximum activity (36.84 U/ml) at 60°C, pH 8.0 and maintained 54% activity at 80°C after incubation for 60 min. The enzyme showed activity against ß-glucan, lichenan, and xylan. Amino acid sequence shared a conserved motif EIDIEF. The predicted three-dimensional homology model of the enzyme showed the presence of catalytic residues Glu105, Glu109 and Asp107, single disulphide bridge between Cys32 and Cys61 and three calcium binding site residues Pro9, Gly45 and Asp207. Presence of calcium ion improves the thermal stability of SU40 ß-1,3-1,4-glucanase. Molecular dynamics simulation studies revealed that the absence of calcium ion fluctuate the active site residues which are responsible for thermostability. The high catalytic activity and its stability to temperature, pH and metal ions indicated that the enzyme ß-1,3-1,4-glucanase by B. subtilis SU40 is a good candidate for biotechnological applications.

5.
ScientificWorldJournal ; 2013: 125385, 2013.
Article in English | MEDLINE | ID: mdl-24470788

ABSTRACT

Bioremediation is one of the most promising methods to clean up polluted environments using highly efficient potent microbes. Microbes with specific enzymes and biochemical pathways are capable of degrading the tobacco alkaloids including highly toxic heterocyclic compound, nicotine. After the metabolic conversion, these nicotinophilic microbes use nicotine as the sole carbon, nitrogen, and energy source for their growth. Various nicotine degradation pathways such as demethylation pathway in fungi, pyridine pathway in Gram-positive bacteria, pyrrolidine pathway, and variant of pyridine and pyrrolidine pathways in Gram-negative bacteria have been reported. In this review, we discussed the nicotine-degrading pathways of microbes and their enzymes and biotechnological applications of nicotine intermediate metabolites.


Subject(s)
Nicotine/metabolism , Biodegradation, Environmental , Biotechnology , Humans , Industrial Microbiology , Metabolic Networks and Pathways , Nicotine/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...